Inventor · disambiguated record
Louie Naumovski
Also filed as: NAUMOVSKI LOUIE
7 granted patents·8 pending applications·38 citations·filing 2012–2023
84Inventor score
Top patents by PatentIndex Score
15 records- 0192US10383948B2Anti-cMet antibody drug conjugates and methods for their useABBVIE INC·Filed 2018·Granted Aug 20, 2019·10 cites·12 claims
- 0291US10603389B2Anti-cMet antibody drug conjugates and methods for their useABBVIE INC·Filed 2019·Granted Mar 31, 2020·3 cites·4 claims
- 0389US9045551B2Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereofABBVIE INC·Filed 2014·Granted Jun 2, 2015·12 cites·11 claims
- 0487US10011657B2Anti-CS1 antibodies and antibody drug conjugatesABBVIE BIOTHERAPEUTICS INC·Filed 2015·Granted Jul 3, 2018·4 cites·16 claims
- 0584US9944720B2Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereofABBVIE INC·Filed 2015·Granted Apr 17, 2018·4 cites·13 claims
- 0681US9163093B2Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereofGU JIJIE·Filed 2013·Granted Oct 20, 2015·5 cites·18 claims
- 0781US2023321271A1ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USEABBVIE BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0876US2022403052A1Anti-dll4/vegf dual variable domain immmunoglobulin and uses thereofABBVIE INC·Filed 2022·Application pending·0 cites
- 0966US2020215200A1ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USEABBVIE INC·Filed 2020·Application pending·0 cites
- 1063US2022211846A1Abt-165 in combination with folinic acid, 5-fluorouracil, and irinotecan for the treatment of cancersABBVIE BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1162US10308713B2Anti-CS1 antibodies and antibody drug conjugatesABBVIE BIOTHERAPEUTICS INC·Filed 2017·Granted Jun 4, 2019·0 cites·20 claims
- 1260US2019031783A1Anti-dll4/vegf dual variable domain immunoglobulin and uses thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 1358US2017348429A1ANTI-cMET ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USEABBVIE BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1454US2019167790A1Abt-165 in combination with folinic acid, 5-fluorouracil, and irinotecan for the treatment of cancersABBVIE BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1536US2013004498A1Dosing for treatment with anti-egfl7 antibodiesGENENTECH INC·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Louie Naumovski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →